Bronchiolitis Obliterans
62
4
6
39
Key Insights
Highlights
Success Rate
81% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
14.5%
9 terminated out of 62 trials
81.3%
-5.3% vs benchmark
18%
11 trials in Phase 3/4
23%
9 of 39 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 39 completed trials
Clinical Trials (62)
Evaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis Obliterans Syndrome
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)
Prospective Evaluations of Infectious Complication in Lung Transplant Recipients
TRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlation With Response to Extracorporeal Photo-aphereSiS
Itacitinib for the Treatment of Bronchiolitis Obliterans Syndrome After Donor Hematopoietic Cell Transplant
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)
Hp129 Xenon Imaging and BOS in Lung Transplantation
Efficacy of Fluticasone Propionate Associated With Salmeterol Using Inhalation Chamber Versus Placebo to Improve the Respiratory Function in Children Over Six Years of Age Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation With a Decline of FEV1 ≥10% From Pre Transplantation
TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
Bronchial Epithelium of Children With Post-infectious Bronchiolitis Obliterans
Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3)
High Intensity Intervallic Training in Children With Bronchiolitis Obliterans
Study of Pulmonary MRI for the Diagnosis of Bronchiolitis Obliterans Syndrome After Allogeneic Stem Cell Transplantation
Measures of Respiratory Health (MRH)
Microparticles and Bronchiolitis Obliterans Syndrome
Evaluating Bronchodilator Response in Patients With Bronchiectasis
Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant Recipients
The Safety and Tolerability of Pirfenidone for BOS After HCT
A Study to Evaluate the Potential of Mesenchymal Stromal Cells to Treat Obliterative Bronchiolitis After Lung Transplantation